Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ross

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Cancer Research|April 1, 1984
Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosineD D Ross, S A Akman, C C Joneckis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugsD L de Valeriola, D D Ross, A Forrest, et al.
The Journal of Infection|September 1, 1989
Mycobacterial disease associated with aplastic anaemiaB C Fox, D D Ross, A B Huang, et al.
Blood|July 1, 1986
Metabolism of ara-C by blast cells from patients with ANLLD D Ross, B W Thompson, C C Joneckis, et al.
Cancer Treatment Reports|July 1, 1985
Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cellsS A Akman, D D Ross, C C Joneckis, et al.
Biochemical Pharmacology|April 1, 1984
Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosineS A Akman, D D Ross, C C Joneckis, et al.
Cytometry|July 1, 1988
Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sortingD D Ross, J V Ordóñez, C C Joneckis, et al.
Seminars in Oncology|June 1, 1987
Studies of ara-C metabolism in acute leukemiaD D Ross, B W Thompson, C C Joneckis, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 8, 1999
Required training in hospice and palliative care at the University of Maryland School of MedicineD D Ross, T Keay, D Timmel, et al.
Blood|August 15, 1993
Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemiaD D Ross, P J Wooten, R Sridhara, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Cancer Research|April 1, 1984
Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosineD D Ross, S A Akman, C C Joneckis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugsD L de Valeriola, D D Ross, A Forrest, et al.
The Journal of Infection|September 1, 1989
Mycobacterial disease associated with aplastic anaemiaB C Fox, D D Ross, A B Huang, et al.
Blood|July 1, 1986
Metabolism of ara-C by blast cells from patients with ANLLD D Ross, B W Thompson, C C Joneckis, et al.
Cancer Treatment Reports|July 1, 1985
Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cellsS A Akman, D D Ross, C C Joneckis, et al.
Biochemical Pharmacology|April 1, 1984
Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosineS A Akman, D D Ross, C C Joneckis, et al.
Cytometry|July 1, 1988
Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sortingD D Ross, J V Ordóñez, C C Joneckis, et al.
Seminars in Oncology|June 1, 1987
Studies of ara-C metabolism in acute leukemiaD D Ross, B W Thompson, C C Joneckis, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 8, 1999
Required training in hospice and palliative care at the University of Maryland School of MedicineD D Ross, T Keay, D Timmel, et al.
Blood|August 15, 1993
Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemiaD D Ross, P J Wooten, R Sridhara, et al.
Pageof 7